Press Releases on December 21, 2022 - EIN Presswire - Press Release Distribution Service

Published on December 21, 2022 - 21:05 GMT

Cognition Therapeutics Announces Participation in Sachs 6th Annual Neuroscience Forum, Biotech Showcase, and BIO Partnering @ JPM ...

PURCHASE, N.Y., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX) (the “Company” or “Cognition”), announced today that the Company’s management team will participate in the 6th Annual Sachs Neuroscience Forum, Biotech Showcase …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 21, 2022 - 21:05 GMT

SpotLite360 Announces Debt Settlement Transaction

DENVER and VANCOUVER, British Columbia, Dec. 21, 2022 (GLOBE NEWSWIRE) -- SPOTLITE360 IOT SOLUTIONS, INC. (“SpotLite360” or the “Company”) (CSE: LITE) (OTC: SPLTF) (Frankfurt: 87A) announces that its board of directors has approved the settlement of an …

Distribution channels: Banking, Finance & Investment Industry, Technology

Published on December 21, 2022 - 21:03 GMT

U.S. Global Investors Announces Selection of Grant Thornton as Its New Auditor, Continuation of Stock Repurchase Program and ...

San Antonio, Texas, Dec. 21, 2022 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (NASDAQ: GROW) (the “Company”), a registered investment advisory firm with longstanding experience in global markets and specialized sectors, today announces that, following …

Distribution channels: Media, Advertising & PR ...

Published on December 21, 2022 - 21:03 GMT

NeuroPace to Present at the 41st Annual J.P. Morgan Healthcare Conference

MOUNTAIN VIEW, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will be participating in the upcoming …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 21, 2022 - 21:02 GMT

Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2023

BOISE, Idaho, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2023, which ended December 1, 2022. Fiscal Q1 2023 highlights Revenue of $4.09 billion versus $6.64 billion for the …

Distribution channels: Business & Economy, Technology ...

Published on December 21, 2022 - 21:01 GMT

Governor Abbott Provides Update On Texas’ Cold Weather Preparedness

December 21, 2022 | Austin, Texas | Press Release Governor Greg Abbott today provided an update on the State of Texas' cold weather response ahead of the polar vortex that is expected to impact Texas beginning tomorrow and lasting through the Christmas …

Distribution channels:

Published on December 21, 2022 - 21:01 GMT

Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference

IRVINE, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced today …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Published on December 21, 2022 - 21:01 GMT

Akero Therapeutics Completes Enrollment of Phase 2b SYMMETRY Study and Announces Expected 2023 Milestones

Results of the main study in patients with compensated cirrhosis due to NASH (F4) expected in fourth quarter of 2023 Results of the cohort D expansion to evaluate EFX in combination with GLP-1 therapy in patients with pre-cirrhotic NASH expected in second …

Distribution channels: Technology ...

Published on December 21, 2022 - 21:01 GMT

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

NOVATO, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of …

Distribution channels: Banking, Finance & Investment Industry, Healthcare & Pharmaceuticals Industry ...

Published on December 21, 2022 - 21:01 GMT

Autolus Announces Partial Exercise of Underwriters' Option to Purchase Additional ADSs

LONDON, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced today that the underwriters of its previously announced public …

Distribution channels: Banking, Finance & Investment Industry ...